메뉴 건너뛰기




Volumn 23, Issue 1, 2007, Pages 1-2

What does star*D tell us about ECT?

(1)  McCall, W Vaughn a  

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; LITHIUM; MIRTAZAPINE; NORTRIPTYLINE; SERTRALINE; VENLAFAXINE;

EID: 34247603547     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/01.yct.0000263249.83549.34     Document Type: Editorial
Times cited : (8)

References (4)
  • 2
    • 0038379113 scopus 로고    scopus 로고
    • National Institute for Clinical Excellence, London, England: National Institute for Clinical Excellence;
    • National Institute for Clinical Excellence. Guidance on the Use of Electroconvulsive Therapy. London, England: National Institute for Clinical Excellence; 2003.
    • (2003) Guidance on the Use of Electroconvulsive Therapy
  • 3
    • 33751338530 scopus 로고    scopus 로고
    • Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A Star*D report
    • Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a Star*D report. Am J Psychiatry. 2006;163:1905-1917.
    • (2006) Am J Psychiatry , vol.163 , pp. 1905-1917
    • Rush, A.J.1    Trivedi, M.H.2    Wisniewski, S.R.3
  • 4
    • 0025308270 scopus 로고
    • Medication resistance and clinical response to electroconvulsive therapy
    • Prudic J, Sackeim HA, Devanand DP. Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Res. 1990;31:287-296.
    • (1990) Psychiatry Res , vol.31 , pp. 287-296
    • Prudic, J.1    Sackeim, H.A.2    Devanand, D.P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.